3.025
price up icon5.59%   0.165
 
loading
前日終値:
$2.86
開ける:
$2.8
24時間の取引高:
216.52K
Relative Volume:
0.83
時価総額:
$71.23M
収益:
$23.26M
当期純損益:
$-63.41M
株価収益率:
-1.2398
EPS:
-2.44
ネットキャッシュフロー:
$-64.56M
1週間 パフォーマンス:
+26.36%
1か月 パフォーマンス:
+31.30%
6か月 パフォーマンス:
+72.57%
1年 パフォーマンス:
+53.30%
1日の値動き範囲:
Value
$2.7519
$3.04
1週間の範囲:
Value
$2.07
$3.60
52週間の値動き範囲:
Value
$1.21
$3.60

Aadi Bioscience Inc Stock (AADI) Company Profile

Name
名前
Aadi Bioscience Inc
Name
セクター
Healthcare (1177)
Name
電話
424-473-8055
Name
住所
17383 SUNSET AVENUE, PACIFIC PALISADES
Name
職員
53
Name
Twitter
Name
次回の収益日
2024-12-06
Name
最新のSEC提出書
Name
AADI's Discussions on Twitter

AADI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AADI
Aadi Bioscience Inc
3.025 71.23M 23.26M -63.41M -64.56M -2.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.05 105.01B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
711.86 78.17B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
630.47 37.48B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.22 30.94B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.97 27.15B 3.30B -501.07M 1.03B -2.1146

Aadi Bioscience Inc Stock (AADI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-27 ダウングレード Piper Sandler Overweight → Neutral
2024-08-21 ダウングレード Jefferies Buy → Hold
2024-08-21 ダウングレード TD Cowen Buy → Hold
2023-12-15 ダウングレード H.C. Wainwright Buy → Neutral
2022-01-11 開始されました Jefferies Buy
2021-10-01 開始されました Cowen Outperform
2021-09-14 開始されました Ladenburg Thalmann Buy
2021-09-08 開始されました Piper Sandler Overweight
すべてを表示

Aadi Bioscience Inc (AADI) 最新ニュース

pulisher
Dec 23, 2024

Aadi Bioscience Enters Into Multiple Strategic Agreements, Including $100M Stock Purchase and License Agreement - Defense World

Dec 23, 2024
pulisher
Dec 22, 2024

Aadi Bioscience Leads 3 Promising US Penny Stocks - Simply Wall St

Dec 22, 2024
pulisher
Dec 21, 2024

Aadi Bioscience rockets 72% on key updates - MSN

Dec 21, 2024
pulisher
Dec 21, 2024

Aadi Bioscience’s Strategic Agreements and Funding Moves - Yahoo Finance

Dec 21, 2024
pulisher
Dec 20, 2024

Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio - Wilson Sonsini

Dec 20, 2024
pulisher
Dec 20, 2024

Asia Deal Watch: Kaken Obtains Aadi Subsidiary And Cancer Drug Fyarro - Scrip

Dec 20, 2024
pulisher
Dec 20, 2024

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday? - Benzinga

Dec 20, 2024
pulisher
Dec 20, 2024

Aadi Bioscience stock soars on licensing and sale deals - Investing.com India

Dec 20, 2024
pulisher
Dec 19, 2024

Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing - Yahoo Finance

Dec 19, 2024
pulisher
Dec 19, 2024

Kaken Pharmaceutical Co., Ltd. agreed to acquire Aadi Subsidiary, Inc. from Aadi Bioscience, Inc. for $100 million. - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Clinical Trials News Live Feed - StockTitan

Dec 19, 2024
pulisher
Dec 15, 2024

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Update - MarketBeat

Dec 15, 2024
pulisher
Dec 11, 2024

AADI Enlists NY Court To Enforce Cancer Drug Award - Law360

Dec 11, 2024
pulisher
Dec 03, 2024

Aadi Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 03, 2024
pulisher
Dec 02, 2024

Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Decreases By 8.8% - MarketBeat

Dec 02, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Cuts Stake in Aadi Bioscience, Inc. (NASDAQ:AADI) - Defense World

Nov 26, 2024
pulisher
Nov 19, 2024

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 19, 2024
pulisher
Nov 12, 2024

US Penny Stocks Under $90M Market Cap To Watch - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

BML Capital Management LLC Takes $4.12 Million Position in Aadi Bioscience, Inc. (NASDAQ:AADI) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Aadi Bioscience Reports Q3 2024 Earnings and Growth - TipRanks

Nov 11, 2024
pulisher
Nov 08, 2024

Aadi Bioscience Faces Potential Financial Strain from Securities Class Action Risks - TipRanks

Nov 08, 2024
pulisher
Nov 06, 2024

Aadi Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Aadi Bioscience Q3 Sales Surge 21% YoY, FYARRO Growth Drives Strong Performance | AADI Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 04, 2024

Aadi Bioscience to Report Third Quarter 2024 Results and Corpora - GuruFocus.com

Nov 04, 2024
pulisher
Oct 30, 2024

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - BioSpace

Oct 30, 2024
pulisher
Oct 29, 2024

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Resu - GuruFocus.com

Oct 29, 2024
pulisher
Oct 16, 2024

Aadi plunges 36% as phase 2 trial for solid tumors asset unlikely to meet goal - MSN

Oct 16, 2024
pulisher
Oct 04, 2024

Aadi Bioscience CEO sells shares worth $18,796 By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Aadi Bioscience CEO sells shares worth $18,796 - Investing.com India

Oct 04, 2024
pulisher
Sep 27, 2024

Wilson Sonsini Defeats $341 Million Arbitration Claim Against Aadi Bioscience - Wilson Sonsini

Sep 27, 2024
pulisher
Sep 23, 2024

DADA’s 2023 Market Dance: Down -64.46% – Time to Invest? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Pacer Advisors Inc. Sells 1,089 Shares of Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

A Glimpse Into The Expert Outlook On Analog Devices Through 8 Analysts - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Nippon Life Global Investors Americas Inc. Makes New $1.10 Million Investment in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Market Highlights: Aditxt Inc (ADTX) Ends on a Low Note at 0.38 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Applied Dna Sciences Inc (APDN) presents a great opportunity, but the stock is slightly overvalued - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

‘It felt like the world had ended’; Aadi Adeel on his father’s passing - TheCurrrent.pk

Sep 23, 2024
pulisher
Sep 23, 2024

Analog Devices (NASDAQ:ADI) Downgraded to "Hold" at Truist Financial - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Magnetar Financial LLC Lowers Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Intech Investment Management LLC Trims Holdings in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

There is no way Aditxt Inc (ADTX) can keep these numbers up - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

AE Wealth Management LLC Has $4.39 Million Stock Holdings in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Edgestream Partners L.P. Acquires New Stake in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Healthcare stock jumps after it enters in an agreement to set up woman and children hospital - Trade Brains

Sep 23, 2024
pulisher
Sep 23, 2024

Adairs Ltd Director Increases Share Holdings - TipRanks

Sep 23, 2024
pulisher
Sep 22, 2024

Profund Advisors LLC Grows Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Quest Investment Management LLC Cuts Holdings in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Summit Trail Advisors LLC Buys 264 Shares of Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Sei Investments Co. Increases Stock Position in Analog Devices, Inc. (NASDAQ:ADI) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Chronicle-Tribune

Sep 22, 2024

Aadi Bioscience Inc (AADI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Aadi Bioscience Inc (AADI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Lennon David James
CHIEF EXECUTIVE OFFICER
Oct 03 '24
Sale
1.94
9,689
18,797
22,869
$69.71
price down icon 0.22%
$18.91
price up icon 1.19%
$39.70
price up icon 0.39%
$362.38
price down icon 0.35%
$179.27
price up icon 0.82%
$113.00
price down icon 0.72%
大文字化:     |  ボリューム (24 時間):